Security key
405024100
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)
CUSIP: 405024100
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common stock, $.01 par value per share
- Shares outstanding
- 46,498,422
- Total 13F shares
- 47,414,656
- Share change
- -3,643,038
- Total reported value
- $2,670,324,561
- Put/Call ratio
- 43%
- Price per share
- $56.36
- Number of holders
- 323
- Value change
- -$243,812,687
- Number of buys
- 167
- Number of sells
- 165
Report period
Q1 2026
Institutions
323
Top holders
10
HAE full security history
Previous quarter: Q4 2025
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 405024100
Recent filing periods:
Top shareholders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
3,163,104
|
$253,522,786 | — | 31 Dec 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
|
Vanguard Portfolio Management |
5.6%
|
2,600,145
|
$146,544,172 | $0 | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
5.3%
|
2,445,817
|
$137,846,246 | $0 | 31 Mar 2026 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
4.6%
|
2,203,351
|
$165,537,761 | -$36,448,193 | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
4.4%
|
2,195,569
|
$135,949,632 | $0 | 31 Mar 2025 | |
| Capital Research Global Investors |
13D/G
|
— |
3.1%
|
1,577,323
|
$97,667,840 | $0 | 31 Mar 2025 | |
| Charles J. Dockendorff |
3/4/5
|
Director |
0.05%
|
25,041
|
$1,868,308 | — | 24 Jul 2025 | |
| Robert E. Abernathy |
3/4/5
|
Director |
0.05%
|
24,981
|
$1,863,832 | — | 24 Jul 2025 | |
| Mark W. Kroll |
3/4/5
|
Director |
0.05%
|
24,757
|
$1,746,853 | +$98,784 | 10 Nov 2025 | |
| Ellen M. Zane |
3/4/5
|
Director |
0.04%
|
19,373
|
$1,445,419 | — | 24 Jul 2025 | |
| Claire Pomeroy |
3/4/5
|
Director |
0.04%
|
16,872
|
$1,258,819 | — | 24 Jul 2025 | |
| Michael J. Coyle. |
3/4/5
|
Director |
0.03%
|
15,394
|
$1,148,546 | — | 24 Jul 2025 | |
| Lloyd E. Johnson |
3/4/5
|
Director |
0.03%
|
12,933
|
$964,931 | — | 24 Jul 2025 | |
| Diane M. Bryant |
3/4/5
|
Director |
0.02%
|
7,126
|
$531,670 | — | 24 Jul 2025 | |
| BlackRock, Inc. |
13F
|
Company |
13%
|
5,820,954
|
$466,549,479 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
4,761,135
|
$381,604,971 | — | 31 Dec 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
8.3%
|
3,865,676
|
$309,882,554 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
1,729,847
|
$138,647,237 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
3%
|
1,380,102
|
$110,615,175 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
2.9%
|
1,326,902
|
$106,351,232 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.8%
|
1,288,432
|
$103,267,825 | — | 31 Dec 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
2.7%
|
1,264,271
|
$101,331,321 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.6%
|
1,226,614
|
$98,313,113 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
1,194,551
|
$95,758,176 | — | 31 Dec 2025 | |
| North Peak Capital Management, LLC |
13F
|
Company |
2.4%
|
1,102,992
|
$88,404,809 | — | 31 Dec 2025 | |
| River Road Asset Management, LLC |
13F
|
Company |
2.4%
|
1,102,140
|
$88,336,521 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
1,092,938
|
$87,602,682 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
2.1%
|
967,593
|
$77,553,000 | — | 31 Dec 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
2%
|
939,727
|
$75,159,365 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
853,379
|
$68,398,327 | — | 31 Dec 2025 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
1.5%
|
716,997
|
$57,467,310 | — | 31 Dec 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.2%
|
580,650
|
$46,539,097 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
577,728
|
$46,304,898 | — | 31 Dec 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.2%
|
573,653
|
$45,978,539 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
1.2%
|
569,173
|
$45,619,216 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
562,949
|
$45,120,430 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
548,921
|
$43,996,018 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
539,677
|
$43,255,111 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.1%
|
526,287
|
$42,181,902 | — | 31 Dec 2025 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
1.1%
|
523,113
|
$41,927,507 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
482,165
|
$38,645,525 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1%
|
464,104
|
$37,197,965 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.93%
|
432,955
|
$34,701,345 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.86%
|
401,758
|
$32,200,904 | — | 31 Dec 2025 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.8%
|
370,308
|
$29,680,193 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
359,190
|
$28,790,000 | — | 31 Dec 2025 | |
| Boston Partners |
13F
|
Company |
0.69%
|
322,667
|
$25,774,881 | — | 31 Dec 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
314,654
|
$25,219,518 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.66%
|
305,215
|
$24,462,947 | — | 31 Dec 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.6%
|
278,314
|
$22,306,867 | — | 31 Dec 2025 |
Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q1 2026
As of 31 Mar 2026,
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by
323 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,414,656 shares.
The largest 10 holders included
BlackRock, Inc., NEUBERGER BERMAN GROUP LLC, AQR CAPITAL MANAGEMENT LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, River Road Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, and FMR LLC.
This page lists
323
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
329
Q1 2026 holders
323
Holder diff
-6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.